<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01687348</url>
  </required_header>
  <id_info>
    <org_study_id>2012-000817-36</org_study_id>
    <secondary_id>2012-05</secondary_id>
    <nct_id>NCT01687348</nct_id>
  </id_info>
  <brief_title>Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy</brief_title>
  <official_title>Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, monocentric, open-label study conducted in women requiring mastectomy and
      eligible for tumescent infiltrative anaesthesia.

      Blood samples will be collected during 48h after start of infiltration. Total and free
      lidocaine concentrations measurements will be determined by gas chromatography. Visual
      analogic scale scores to evaluate postoperative pain and all data concerning analgesic drugs
      and adverse effects will be collected.

      Population pharmacokinetic parameters will be estimated using NONMEM software and covariates
      influence on parameters variability will be tested.

      Primary outcome value: Population pharmacokinetic parameters with possible covariates
      influence on variability.

      Patients and period of study: n=30 patients enrolled during 24 months, total study duration:
      30 months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak Plasma Concentration (Cmax) of 'drug lidocaine'&quot;</measure>
    <time_frame>36 MONTHS</time_frame>
    <description>during tumescent infiltrative anaesthesia for mastectomy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesic postoperative efficacy</measure>
    <time_frame>36 MONTHS</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Mastectomy</condition>
  <arm_group>
    <arm_group_label>lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lidocaine traitment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine aguettant</intervention_name>
    <arm_group_label>lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Surgery carcinologique of the breast requiring a mastectomy under tumescente local
             anesthetic

          -  Age: upper to 18 years

          -  Weight: upper to 50 kg

        Exclusion Criteria:

          -  Cutaneous infection in the point of draining

          -  Clinical Disorder(Confusion) of the coagulation

          -  Retreat(Withdrawal) of the consent in the course of protocol

          -  Unwanted Effect engraves(burns) requiring the stop(ruling) of the
             treatment(processing)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BERNARD BELAIGUES</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique h√¥pitaux de Marseille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2012</study_first_submitted>
  <study_first_submitted_qc>September 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2012</study_first_posted>
  <last_update_submitted>January 22, 2016</last_update_submitted>
  <last_update_submitted_qc>January 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

